Clinical Translation
Through its affiliation with the University of Pittsburgh Medical Center, the McGowan Institute for
Regenerative Medicine has access to one of the nation's finest health systems. In fact, the University of
Pittsburgh Medical Center is consistently ranked by U.S. News and World Report as one of the best health
systems in the country, with a well-established and well-organized clinical trial infrastructure, and a
large, diverse population from which to draw study subjects.
The Institute's Clinical Translation Team, under the direction of Robert L. Kormos, MD, professor of
Cardiac Surgery and medical director of the McGowan Institute, consists of UPMC clinicians who are
leaders in their respective fields, identifies potential clinical applications for Institute-developed
therapies, and assists in developing clinical protocols prior to Internal Review Board submission.
Through collaborations with the Departments of Medicine, Surgery and Rehabilitation Medicine, the
Clinical Translation Team provides a seamless transition from bench top to bedside with the goal of
providing excellence in clinical care for patients with end-stage, end-organ disease through mechanisms
of repair, recovery and replacement.